Almost A Third Of New FDA-Approved Pharmaceuticals Have Post-Trial Safety Events 

Almost a third of new therapeutic drugs released onto the US market with Food and Drug Administration (FDA) approval subsequently have what are called “saf

Source: Almost A Third Of New FDA-Approved Pharmaceuticals Have Post-Trial Safety Events | IFLScience

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s